Targeting hypoxia-related metabolism molecules: How to improve tumour immune and clinical treatment?
Tumour metabolism has gradually come to be regarded as a key target to prevent tumour growth and metastasis. The unique metabolic characteristics of tumours enable them to maintain self-proliferation in abnormal environments. In recent years, the necessity of hypoxia in the tumour microenvironment h...
Main Authors: | Bing Liang, Lin Deng, Xiuhua Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222013063 |
Similar Items
-
Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy
by: Mingyao Huang, et al.
Published: (2020-09-01) -
Role of hypoxia in the tumor microenvironment and targeted therapy
by: Gaoqi Chen, et al.
Published: (2022-09-01) -
Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
by: Rongrong Han, et al.
Published: (2021-05-01) -
Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy
by: Zhe Fu, et al.
Published: (2021-04-01) -
Transcriptomic Analysis of Human Astrocytes In Vitro Reveals Hypoxia-Induced Mitochondrial Dysfunction, Modulation of Metabolism, and Dysregulation of the Immune Response
by: Scott P. Allen, et al.
Published: (2020-10-01)